Home › Lupus › Colorado › Aurora
Lupus clinical trials in Aurora, CO
4 studies for Lupus are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
RecruitingPhase 3
- University of Colorado Denver, Aurora
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Colorado Denver, Aurora
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50719, Aurora
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
RecruitingPhase 2
- University of Colorado, Aurora
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX14 studies
- Durham, NC12 studies
- Washington, DC11 studies
- Miami, FL10 studies
- Oklahoma City, OK9 studies
- San Diego, CA8 studies
- Tampa, FL8 studies
- Boston, MA8 studies
- Chicago, IL8 studies
- Philadelphia, PA8 studies
- Santa Monica, CA7 studies
Other studies in Aurora
- Cancer (all types)34 studies
- Colorectal Cancer33 studies
- Non-Small Cell Lung Cancer31 studies
- Breast Cancer30 studies
- Type 1 Diabetes26 studies
- Metastatic Cancer24 studies
- Ovarian Cancer23 studies
- Obesity20 studies
- Lung Cancer19 studies
- Melanoma18 studies
- Heart Failure17 studies
- Prostate Cancer17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.